Deal date
KANDO id: 750126
Financial Transaction:
Series C
Color Genomics Inc
Currency
United States Dollar
Value in original currency
80,000,000
Value in USD
80,000,000
Note
“This new funding will enable Color to continue developing new tests for hereditary conditions where the science is clear and the results are actionable — and new services that help our clients proactively manage their own health.”
Lead investor
| Investor | Country | Notes | |
|---|---|---|---|
|
General Catalyst PartnersVenture capital firm that makes early-stage and transformational investments. |
United States |
Round participants
| Investor | Country | Notes | |
|---|---|---|---|
|
Charles River Ventures(CRV)Independent venture capital firm |
United States | |
|
Emerson Collective |
United States |